FDA rapped for unpredictability on 510(K) approval process
Acknowledging the need for greater transparency and coordination with manufacturers, the FDA stands by its stringent and notoriously slower 510(k) medical device approval process relative to other countries. Yet device manufacturers complain that the agency's unpredictable procedures, not its speed, are the key reason for industry's growing introduction of products outside the U.S. market. As the FDA gears up to make major changes to the approval process for medical devices in September, including a 25-step improvement plan, Northwestern University in Chicago released a study of 356 representatives of medical device manufacturers with experience in the FDA 510(k) approval process. The National Press Club hosted a forum this week with the study's lead investigators and a panel that included current and former executives from the FDA and medical industry, as well as consultants.
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- Readmissions: No Quick Fix to Costly Hospital Challenge
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- 4 Tips for Managing Employed Physicians
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers
- House Calls Key to Pioneer ACO Success